Inoculation of the 4th domestic "Novaxovid" vaccine begins in Itabashi, Tokyo

Mass inoculation of Novabax vaccine, the fourth new corona vaccine in Japan, began on the 3rd in Itabashi-ku, Tokyo.

The Novabax vaccine has a different mechanism from Pfizer and Moderna, and is expected to be given to people who have had an allergic reaction with previous vaccines or who have hit AstraZeneca up to the second time.

In Tokyo, in addition to the large-scale inoculation venue in Tokyo, inoculation was carried out in four local governments, Shinagawa Ward, Itabashi Ward, Katsushika Ward, and Tama City, of which Itabashi Ward began inoculation on the 3rd.

On the 3rd, about 150 people who booked in advance were vaccinated after an interview at the mass vaccination site in the ward.

According to the ward, 90% of the slots that can be reserved are filled on the 3rd, and reservations for the relatively young generation from 20s to 40s are conspicuous, so people who have allergies and have refrained from vaccination until now I was visiting.

A man in his 40s, who said he had been vaccinated for the first time, said, "I was hesitant to get the vaccination, but I heard that there were few side reactions and came to receive it."

Yutaka Kunieda, chief of the Itabashi Ward Preventive Measures Division, said, "I want people who are hesitant to get vaccinated because of side reactions to know that there are vaccine options."

Tetsuya Matsumoto, Chief Professor, International University of Health and Welfare "For new options"

About the Novabax vaccine Tetsuya Matsumoto, chief professor of the International University of Health and Welfare, said, "Since the Novabax vaccine has fewer side reactions than the Physer and Moderna vaccines that use'mRNA', I have had an allergic reaction with the'mRNA'vaccine. It will be a new option for people and those who have had a strong side reaction and have forgotten the vaccination after that. "

In addition, "The'mRNA'vaccine has a strong inflammatory reaction in the body, but the effect is also high. The effect of the Novabax vaccine is slightly lower, but the irritation to the body is weak. I want you to do it. "

He added, "Although the number of infected people in Tokyo is declining, there is still a risk because it has not decreased drastically. It is important to vaccinate and prepare for infection."